Trial Profile
A Phase II Trial of Capecitabine and Docetaxel in the Treatment of Advanced and Recurrent Cervical Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary)
- Indications Adenosquamous carcinoma; Cervical cancer
- Focus Therapeutic Use
- 13 Feb 2013 New trial record